Gene · 5696
Papers2,476
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,476
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia. | Mol Cancer | 2023 | 38049829 | PubTator, text mining | PubMed |
| Functional and spatial proteomics profiling reveals intra- and intercellular signaling crosstalk in colorectal cancer. | iScience | 2023 | 38047086 | PubTator, text mining | PubMed |
| Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study. | Front Med (Lausanne) | 2023 | 38034538 | PubTator, text mining | PubMed |
| Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain. | Front Endocrinol (Lausanne) | 2023 | 38034001 | PubTator, text mining | PubMed |
| The effect of TLR3 priming conditions on MSC immunosuppressive properties. | Stem Cell Res Ther | 2023 | 38031182 | PubTator, text mining | PubMed |
| CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma. | J Exp Clin Cancer Res | 2023 | 37993874 | PubTator, text mining | PubMed |
| Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγ. | Cancer Res Commun | 2023 | 37991387 | PubTator, text mining | PubMed |
| HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma. | J Transl Med | 2023 | 37974228 | PubTator, text mining | PubMed |
| A state-of-the-art review on the NRF2 in Hepatitis virus-associated liver cancer. | Cell Commun Signal | 2023 | 37946175 | PubTator, text mining | PubMed |
| Investigation of immune-related diseases using patient-derived induced pluripotent stem cells. | Inflamm Regen | 2023 | 37876023 | PubTator, text mining | PubMed |
| A prognostic mathematical model based on tumor microenvironment-related genes expression for breast cancer patients. | Front Oncol | 2023 | 37860187 | PubTator, text mining | PubMed |
| Proteogenomics Reveal the Overexpression of HLA-I in Cancer. | J Proteome Res | 2023 | 37857377 | PubTator, text mining | PubMed |
| Molecular markers of type II alveolar epithelial cells in acute lung injury by bioinformatics analysis. | Sci Rep | 2023 | 37853056 | PubTator, text mining | PubMed |
| SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8+ T cell responses. | Heliyon | 2023 | 37842619 | PubTator, text mining | PubMed |
| Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patients. | Neoplasia | 2023 | 37839160 | PubTator, text mining | PubMed |
| The Role of Autophagy in Brain Tumors. | Cancers (Basel) | 2023 | 37835495 | PubTator, text mining | PubMed |
| Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells. | Front Immunol | 2023 | 37818353 | PubTator, text mining | PubMed |
| M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics. | Arthritis Res Ther | 2023 | 37784134 | PubTator, text mining | PubMed |
| Nature and nurture: understanding phenotypic variation in inborn errors of immunity. | Front Cell Infect Microbiol | 2023 | 37780853 | PubTator, text mining | PubMed |
| Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas. | Exp Mol Med | 2023 | 37779141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5696/papers?page=8